Journals / Türk Biyokimya Dergisi / 2000 / Cilt: 25 - Sayı: 1

Distribution of serum fatty acids in coroner artery disease

Koroner kalp hastalığında serum yağ asitleri dağılımı

Pages
21–28
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These data support the hypothesis that polyunsaturated fatty acids have an antiatherosclerotic effect through regulating the metabolism of blood lipids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is known that atherosclerosis is the main cause of mortality in many countries.
📊
Key Findings & Data:It has been believed for a long time that polyunsaturated fatty acids protect from coroner artery disease (CAD).
💡
Conclusion & Impact:These data support the hypothesis that polyunsaturated fatty acids have an antiatherosclerotic effect through regulating the metabolism of blood lipids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is known that atherosclerosis is the main cause of mortality in many countries. There are many studies relevant to the role of blood lipids in atherosclerosis. Whereas the role of fatly acids in this disease is still controversial. It has been believed for a long time that polyunsaturated fatty acids protect from coroner artery disease (CAD). Recently it has been advised by some authors that to replace polyunsaturated fatly acids with monounsaturated fatty acids in diet is beneficial. In this study, we aimed to determine and compare the serum levels of triglycerides, total cholesterol, HDL-, LDL-cholesterol, phospholipids together with saturated and unsaturated total fatty acid percentages in CAD diagnosed patients (Group A, n=30) and control group (Group B, n=28). We found higher levels of serum triglycerides, total cholesterol, LDL-cholesterol and lower levels of HDL-cholesterol in CAD group in comparison with control group. In addition, serum total 14:0, 16:0, 18:1 fatty acids percentages were found to be higher and serum total 18:2 ω6 fatty acids lower in CAD group. There was a positive correlation between serum triglyceride and phospholipid levels, and serum total 14:0, 16:0, 16:1, 18:1 saturated and monounsaturated fatty acids and a negative correlation between serum triglyceride and phospholipid levels and serum total 18:2 ω6 ve 20:4 ω6 polyunsaturated fatty acids in CAD group. In addition, there was a negative correlation between serum total cholesterol and LDL-cholesterol and serum 18:3 ω6 polyunsaturated fatty acids in CAD group. There was a positive correlation between serum HDL-cholesterol levels and 20:4 (.06 polyunsaturated fatty acids in CAD and control group. These data support the hypothesis that polyunsaturated fatty acids have an antiatherosclerotic effect through regulating the metabolism of blood lipids.

Özet

Ateroskleroza bağlı ölümler bir çok ülkede mortalitede birinci sırada yer almaktadır. Kan lipidlerinin, aterosklerozun gelişimindeki rolü ile ilgili bir çok çalışma yapılmıştır. Bununla birlikte, bu hastalığın gelişiminde yağ asitlerinin rolü ise hala tartışmalıdır. Uzun süreden beri poliansatüre yağ asitlerinin ateroskleroza karşı koruyucu olduğuna inanılmıştır. Günümüzde ise bu görüş tartışılmakta, hatta bazı uzmanlar tarafından diyetteki poliansatüre yağ asitlerinin, monoansatüre yağ asitleri ile yer değiştirmesi konusunda görüşler ileri sürülmektedir. Bu çalışmada, Koroner Kalp Hastalığı (KKH) tanısı konmuş hastalarda (Grup A, n=30) serum glukoz, trigliserid, total kolesterol, HDL, LDL kolesterol ve fosfolipid düzeyleri ile satüre ve ansatüre total yağ asidi yüzdelerini saptayıp, kontrol (Grup B, n=28) grubu ile karşılaştırmayı amaçladık. KKH grubunda serum trigliserid, total kolesterol ve LDL-kolesterol düzeyleri yüksek, HDL-kolesterol düzeyleri ise düşük bulundu. Ayrıca, bu grupta serum 14:0, 16:0, 18:1 total yağ asidi yüzde oranları yüksek, 18:2 ω6 yağ asidi yüzde oranları ise düşük belirlendi. Diğer taraftan, KKH grubunda serum trigliserid ve fosfolipid düzeyleri ile total 14:0, 16:0, 16:1, 18:1 yağ asitleri arasında pozitif korelasyon, 18:2 ω6 ve 20:4 ω6 yağ asitleri arasında ise negatif korelasyon belirlendi. Ayrıca, KKH grubunda serum total ve LDL-kolesterol düzeyleri ile 18:3 ω6 yağ asitleri arasında negatif ilişki belirlendi. Öte yandan KKH ve kontrol grubunda serum HDL-kolesterol düzeyleri ile 20:4 ω6 yağ asitleri arasında pozitif korelasyon saplandı. Bu bulgular, poliansatüre yağ asitlerinin serum lipidlerinin metabolizmasını düzenleyerek, lipid profilini antiaterosklerotik yönde değiştirdiği görüşünü desteklemektedir.

🔖

Cite This Article

KÖSEOĞLU, M. H., FADILOĞLU, M. (2022). Distribution of serum fatty acids in coroner artery disease. Türk Biyokimya Dergisi, Cilt: 25 - Sayı: 1, 21–28. https://ajindex.com/articles/621458

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Mahley RW; Lipoprotein metabolism and molecular biology of atherogenesis. Merck Co., Inc., Wh.itehouse Station, New Jersey, USA, 1993 2. Yılmaz F, Özaydın M, Yüce G; Ateroskleroz ve aterogenez. İzmir Devlet Hastanesi Tıp Dergisi. 1994; 4: p-398-405 3. Kuo PT; Dyslipidemia and coronary artery disease. Clin Cardiol. 17: 519-527 1994 4. Marinetti VG; Discorders of Lipid Metebolism. Pleaum Press, New York. 1990;p 121-132 5. Thompson GR; A handbook of byperlipidemia. Merck Co., Inc., Current Science Ltd. London 1989 6. Merz B; Is it time to include lipoprotein analysis in cholesterol screening?(Medical News Perspectives). Jama 1989; 261-4 479-498 7. Shaefer LE, Lichtensitein AH, Lamon S; Lipoproteins, nutrition, aging, and atherosclerosîs. Am J Clin Nutr. 1995 61(suppl): 726s-40s 8. Gotto AM Jr: Hypertriglyceridemia: risks and perspeetives. Am J Cardiol. 1992; 14;70(19);19H-25H 9. Tietz, W,Norbert: Textbook of Clinical Chemistry. W.B. Saunders Company, Philadelphia. 1994 10. Mensink RP; Dieatry monounsaturated fatty acids and serum lipoprotein levels in healthy subjects. Atherosclerosis. 110; (suppl) 65-68 1994 11. Zilversmit DB: Atherogenic nature of thiglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995; 41(1): 153-8 12. Boberg M, Vessby B, Croon LB; Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with IHD. Atherosclerosis.1985; 58:49-63 13. Tamuğur E; Koroner arter hastalarında ve kontrol grubnda serum trigliserid, total kolesterol, HDL- ve LDL-kolesterol değerleri üzerinde çalışmalar. Uzmanlık tezi, İzmir. 1989; s. 14-39 14. Önvural B, Durmuş M, Güneri S, Küseoğlu MH; Apolipaprotein A1 ve Apolipop rotein B'nin koroner arter hastalığı riskini belirlemedeki değeri. PA.Ü.T.F. Dergisi. 1996, 2 (1-3); 9-13 15. Schwartzkopff W, Schleicher J, Pottins I, Yu SB, Han CZ, Du DY; Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction. Atherosclerosis. 1990; 82(3): 253-9 16. Logan RL, Riersman RA, Thompson M; Riask factors ischaemic heart disease in normal men aged 40. Lancet. 1978 ii: 949 17. Schrade W, Biegler R, Böehler E; Fatty-acid distribution in the lipid fractions of healty persons of differnt age, patients with atherosclerosis. J Atherosc Res. 1967: 1:47 18. Wood DA, Riemersma RA, Buttler SA, Thomson MA; Linoleic and eicosapentaenooic acids in adipose tissue and platelets and risk of c